Publication:
Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

dc.contributor.authorBarrios, Vivencio
dc.contributor.authorCinza-Sanjurjo, Sergio
dc.contributor.authorGarcía-Alegría, Javier
dc.contributor.authorFreixa-Pamias, Román
dc.contributor.authorLlordachs-Marques, Frederic
dc.contributor.authorMolina, Carlos A
dc.contributor.authorSantamaría, Amparo
dc.contributor.authorVivas, David
dc.contributor.authorSuárez Fernandez, Carmen
dc.date.accessioned2023-05-03T13:38:11Z
dc.date.available2023-05-03T13:38:11Z
dc.date.issued2022-07-13
dc.description.abstractCompared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.
dc.identifier.doi10.2217/fca-2022-0044
dc.identifier.essn1744-8298
dc.identifier.pmid35822847
dc.identifier.unpaywallURLhttps://doi.org/10.2217/fca-2022-0044
dc.identifier.urihttp://hdl.handle.net/10668/20491
dc.issue.number9
dc.journal.titleFuture cardiology
dc.journal.titleabbreviationFuture Cardiol
dc.language.isoen
dc.organizationHospital Costa del Sol
dc.page.number743-754
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOVID-19
dc.subjectanticoagulation
dc.subjectatrial fibrillation
dc.subjectdirect oral anticoagulant
dc.subjecttelemedicine
dc.subjectvitamin K antagonist
dc.subject.meshAdministration, Oral
dc.subject.meshAnticoagulants
dc.subject.meshAtrial Fibrillation
dc.subject.meshCOVID-19
dc.subject.meshHumans
dc.subject.meshStroke
dc.subject.meshTelemedicine
dc.titleRole of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dspace.entity.typePublication

Files